{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T06:56:17Z","timestamp":1785308177309,"version":"3.55.0"},"reference-count":26,"publisher":"Japan Society of Smooth Muscle Research","issue":"0","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Smooth Muscle Res.","J Smooth Muscle Res"],"published-print":{"date-parts":[[2017]]},"DOI":"10.1540\/jsmr.53.20","type":"journal-article","created":{"date-parts":[[2017,3,2]],"date-time":"2017-03-02T22:11:10Z","timestamp":1488492670000},"page":"20-30","source":"Crossref","is-referenced-by-count":2,"title":["Changes in renal vessels associated with long-term administration of angiotensin converting enzyme inhibitor in Zucker fatty rats"],"prefix":"10.1540","volume":"53","author":[{"given":"Kazushige","family":"Nakanishi","sequence":"first","affiliation":[{"name":"Department of General Medicine and Emergency Care, Faculty of Medicine, Toho University"},{"name":"Showa Women\u2019s University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohko","family":"Nagai","sequence":"additional","affiliation":[{"name":"Department of General Medicine and Emergency Care, Faculty of Medicine, Toho University"},{"name":"Tokyo Kidney Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuo","family":"Akimoto","sequence":"additional","affiliation":[{"name":"Department of General Medicine and Emergency Care, Faculty of Medicine, Toho University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuaki","family":"Yamanaka","sequence":"additional","affiliation":[{"name":"Tokyo Kidney Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"435","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Tominaga, N, Robert, A, Izuhara, Y, Ohtomo, S, Dan, T, Chihara, K, Kurokawa, K, Van Ypersele de Strihou, C, Miyata, T. Very high doses of valsartan provide renoprotection independently of blood pressure in a type 2 diabetic nephropathy rat model. Nephrology (Carlton). 2009; 14(6): 581\u20137.","DOI":"10.1111\/j.1440-1797.2009.01143.x"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Tylicki, L, Lizakowski, S, Rutkowski, B. Renin-angiotensin-aldosterone system blockade for nephroprotection: current evidence and future directions. J Nephrol. 2012; 25(6): 900\u201310.","DOI":"10.5301\/jn.5000134"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Parving, HH, Lehnert, H, Br\u00f6chner-Mortensen, J, Gomis, R, Andersen, S, Arner, P; Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria Study Group. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med. 2001; 345(12): 870\u20138.","DOI":"10.1056\/NEJMoa011489"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Brenner, BM, Cooper, ME, de Zeeuw, D, Keane, WF, Mitch, WE, Parving, HH, Remuzzi, G, Snapinn, SM, Zhang, Z, Shahinfar, S; RENAAL Study Investigators. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001; 345(12): 861\u20139.","DOI":"10.1056\/NEJMoa011161"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Jackson, DG, Jones, HB. Histopathological and ultrastructural changes in the juxtaglomerular apparatus of the rat following administration of ZENECA ZD6888 (2-ethyl-5,6,7,8-tetrahydro-4-[(2\u2032-(1H-tetrazol-5-yl)biphenyl-4-yl)- methoxy]quinoline), an angiotensin II antagonist. Toxicol Pathol. 1995; 23(1): 7\u201315.","DOI":"10.1177\/019262339502300102"},{"key":"6","unstructured":"6. Owen, RA, Molon-Noblot, S, Hubert, MF, Siegl, PK, Eydelloth, RS, Keenan, KP. Juxtaglomerular cell hypertrophy and hyperplasia induced in rhesus monkeys by angiotensin II receptor antagonists. Lab Invest. 1994; 71(4): 543\u201351."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Nakanishi, K, Nagai, Y, Honglan Piao, , Akimoto, T, Kato, H, Yanakieva-Georgieva, N, Ishikawa, Y, Yoshihara, K, Ito, K, Yamanaka, N, Oite, T. Changes in renal vessels following the long-term administration of an angiotensin II receptor blocker in Zucker fatty rats. J Renin Angiotensin Aldosterone Syst. 2011; 12(2): 65\u201374.","DOI":"10.1177\/1470320310387844"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Ravid, M, Savin, H, Jutrin, I, Bental, T, Katz, B, Lishner, M. Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. Ann Intern Med. 1993; 118(8): 577\u201381.","DOI":"10.7326\/0003-4819-118-8-199304150-00001"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Ravid, M, Lang, R, Rachmani, R, Lishner, M. Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study. Arch Intern Med. 1996; 156(3): 286\u20139.","DOI":"10.1001\/archinte.1996.00440030080010"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Jafar, TH, Schmid, CH, Landa, M, Giatras, I, Toto, R, Remuzzi, G, Maschio, G, Brenner, BM, Kamper, A, Zucchelli, P, Becker, G, Himmelmann, A, Bannister, K, Landais, P, Shahinfar, S, de Jong, PE, de Zeeuw, D, Lau, J, Levey, AS. Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. Ann Intern Med. 2001; 135(2): 73\u201387.","DOI":"10.7326\/0003-4819-135-2-200107170-00007"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Nagai, Y, Nakanishi, K, Yamanaka, N. Direct Renin Inhibitor is Better than Angiotensin II Receptor Blocker for Intrarenal Arterioles. Kidney Blood Press Res. 2016; 41(5): 561\u20139.","DOI":"10.1159\/000443459"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. D\u2019Agati, VD, Fogo, AB, Bruijn, JA, Jennette, JC. Pathologic classification of focal segmental glomerulosclerosis: a working proposal. Am J Kidney Dis. 2004; 43(2): 368\u201382.","DOI":"10.1053\/j.ajkd.2003.10.024"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Nagai, Y, Nakanishi, K, Akimoto, T, Yamanaka, N. Proliferative changes of renal arteriolar walls induced by administration of angiotensin II receptor blocker are frequent in juvenile rats. J Renin Angiotensin Aldosterone Syst. 2014; 15(4): 440\u20139.","DOI":"10.1177\/1470320313502105"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Racasan, S, Hahnel, B, van der Giezen, DM, Blezer, EL, Goldschmeding, R, Braam, B, Kriz, W, Koomans, HA, Joles, JA. Temporary losartan or captopril in young SHR induces malignant hypertension despite initial normotension. Kidney Int. 2004; 65(2): 575\u201381.","DOI":"10.1111\/j.1523-1755.2004.00410.x"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Hashimoto, K, Imai, K, Yoshimura, S, Ohtaki, T. Twelve month studies on the chronic toxicity of captopril in rats. J Toxicol Sci. 1981; 6(Suppl 2): 215\u201346.","DOI":"10.2131\/jts.6.SupplementII_215"},{"key":"16","unstructured":"16. Zaki, FG, Keim, GR, Takii, Y, Inagami, T. Hyperplasia of juxtaglomerular cells and renin localization in kidney of normotensive animals given captopril. Electron microscopic and immunohistochemical studies. Ann Clin Lab Sci. 1982; 12(3): 200\u201315."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Kim, HS, Aikawa, M, Kimura, K, Kuro-o, M, Nakahara, K, Suzuki, T, Katoh, H, Okamoto, E, Yazaki, Y, Nagai, R. Ductus arteriosus. Advanced differentiation of smooth muscle cells demonstrated by myosin heavy chain isoform expression in rabbits. Circulation. 1993; 88(4 Pt 1): 1804\u201310.","DOI":"10.1161\/01.CIR.88.4.1804"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Endemann, DH, Schiffrin, EL. Endothelial dysfunction. J Am Soc Nephrol. 2004; 15(8): 1983\u201392.","DOI":"10.1097\/01.ASN.0000132474.50966.DA"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Owens, GK, Kumar, MS, Wamhoff, BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev. 2004; 84(3): 767\u2013801.","DOI":"10.1152\/physrev.00041.2003"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Gomez, RA, Belyea, B, Medrano, S, Pentz, ES, Sequeira-Lopez, ML. Fate and plasticity of renin precursors in development and disease. Pediatr Nephrol. 2014; 29(4): 721\u20136.","DOI":"10.1007\/s00467-013-2688-0"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Sakoda, M, Ichihara, A, Kaneshiro, Y, Takemitsu, T, Nakazato, Y, Nabi, AH, Nakagawa, T, Suzuki, F, Inagami, T, Itoh, H. (Pro)renin receptor-mediated activation of mitogen-activated protein kinases in human vascular smooth muscle cells. Hypertens Res. 2007; 30(11): 1139\u201346.","DOI":"10.1291\/hypres.30.1139"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Greco, CM, Camera, M, Facchinetti, L, Brambilla, M, Pellegrino, S, Gelmi, ML, Tremoli, E, Corsini, A, Ferri, N. Chemotactic effect of prorenin on human aortic smooth muscle cells: a novel function of the (pro)renin receptor. Cardiovasc Res. 2012; 95(3): 366\u201374.","DOI":"10.1093\/cvr\/cvs204"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Remuzzi, G, Benigni, A, Remuzzi, A. Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes. J Clin Invest. 2006; 116(2): 288\u201396.","DOI":"10.1172\/JCI27699"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Ferrario, CM, Jessup, J, Chappell, MC, Averill, DB, Brosnihan, KB, Tallant, EA, Diz, DI, Gallagher, PE. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation. 2005; 111(20): 2605\u201310.","DOI":"10.1161\/CIRCULATIONAHA.104.510461"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Ripley, E. Complementary effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in slowing the progression of chronic kidney disease. Am Heart J. 2009; 157(6 Suppl): S7\u201316.","DOI":"10.1016\/j.ahj.2009.04.008"},{"key":"26","unstructured":"26. Motawi, TK, El-Maraghy, SA, Senousy, MA. J Biochem Mol. Effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on streptozotocin-induced diabetic nephropathy. Toxicol. 2013; 27: 378\u201387."}],"container-title":["Journal of Smooth Muscle Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsmr\/53\/0\/53_0470\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T11:47:41Z","timestamp":1498391261000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsmr\/53\/0\/53_0470\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":26,"journal-issue":{"issue":"0","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1540\/jsmr.53.20","relation":{},"ISSN":["0916-8737","1884-8796"],"issn-type":[{"value":"0916-8737","type":"print"},{"value":"1884-8796","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}